185 related articles for article (PubMed ID: 3133813)
21. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
22. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis.
Rowbotham BJ; Whitaker AN; Masci PP
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):653-61. PubMed ID: 2133245
[TBL] [Abstract][Full Text] [Related]
23. The detection of D-dimer in plasma by enzyme immunoassay: improved discrimination is obtained with a more specific signal antibody.
Hart R; Bate I; Dinh D; Elms M; Bundesen P; Hillyard C; Rylatt DB
Blood Coagul Fibrinolysis; 1994 Apr; 5(2):227-32. PubMed ID: 7519890
[TBL] [Abstract][Full Text] [Related]
24. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
[TBL] [Abstract][Full Text] [Related]
26. [A test for the detection of fibrin in the plasma].
Franke M; Hafter R; von Hugo R; Röbl M; Graeff H
Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):105-9. PubMed ID: 3956964
[TBL] [Abstract][Full Text] [Related]
27. The importance of antibody specificity in measuring cross-linked fibrin degradation products by ELISA.
Eisenberg PR; Rylatt DB; Rusticali F; Ferrini D; Ottani F; Galvani M
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):105-13. PubMed ID: 9518041
[TBL] [Abstract][Full Text] [Related]
28. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
Gupta PK; Gupta M; Chatterjee T; Saxena R
Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
[TBL] [Abstract][Full Text] [Related]
29. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
Brenner B; Francis CW; Marder VJ
J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
[TBL] [Abstract][Full Text] [Related]
30. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
Barsotti A; Savarino A
Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the assay for fibrin derivatives using monoclonal antibodies to D-dimer].
Arai M; Kuroso K; Ikematsu S; Fujimaki M; Fukutake K
Rinsho Byori; 1986 Feb; 34(2):157-61. PubMed ID: 3517428
[No Abstract] [Full Text] [Related]
33. Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation.
Brenner B; Francis CW; Totterman S; Kessler CM; Rao AK; Rubin R; Kwaan HC; Gabriel KR; Marder VJ
Circulation; 1990 Jun; 81(6):1818-25. PubMed ID: 2111742
[TBL] [Abstract][Full Text] [Related]
34. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of antibody reactivity for FDP D-dimer fragments by Western blotting].
Wakabayashi S; Ishikawa S; Hirota-Kawadobora M; Fujihara N; Kamijyo Y; Yamauchi K; Terasawa F; Okumura N; Katsuyama T
Rinsho Byori; 2008 Jun; 56(6):449-54. PubMed ID: 18646629
[TBL] [Abstract][Full Text] [Related]
36. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
37. Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma.
Carroll RC; Lockhart MS; Taylor FB
J Lab Clin Med; 1984 May; 103(5):695-703. PubMed ID: 6232329
[TBL] [Abstract][Full Text] [Related]
38. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
[TBL] [Abstract][Full Text] [Related]
39. Immunoenzyme histochemical localization of fibrin degradation products in tissues.
Emeis JJ; Lindeman J; Nieuwenhuizen W
Am J Pathol; 1981 Jun; 103(3):337-44. PubMed ID: 7015871
[TBL] [Abstract][Full Text] [Related]
40. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]